Cognitive impairment in multiple sclerosis (MS) primarily applies to information processing speed (IPS).
Objective:
To evaluate psychometric properties of a new digit/symbol substitution test in healthy subjects and patients with MS, and assess its ability to detect IPS impairment in patients with MS.
Methods:
A sample of MS patients, 60 relapsing–remitting (RRMS) and 41 primary progressive MS (PPMS), and 415 healthy controls (HCs) underwent an IPS battery, including assessment of reaction times of subtests of the Test of Attentional Performance battery and a newly developed in-house digit/symbol substitution task, the Computerised Speed Cognitive Test (CSCT). The CSCT was additionally evaluated in a second cohort of 31 RRMS and 12 progressive MS patients, for comparison with the Symbol Digit Modalities Test (SDMT).
Results:
The CSCT had good reliability in both HCs and patients with MS. It showed a weak practice effect at the 6-month time point. This test had good ecological validity in MS patients. There was a strong correlation between the CSCT with the SDMT and with other IPS tests in patients with MS. The CSCT had the best sensitivity for predicting IPS impairment and was one of the most accurate tests among the IPS battery.
Conclusion:
The CSCT appeared as a good candidate for detecting IPS impairment in MS patients.
DeloireMRuetAHamelD. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler2010; 16: 581–587.
4.
MorrowSADrakeAZivadinovR. Predicting loss of employment over three years in multiple sclerosis: Clinically meaningful cognitive decline. Clin Neuropsychol2010; 24: 1131–1145.
5.
RuetADeloireMHamelD. Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: A 7-year longitudinal study. J Neurol2012; Vol: page–p. J Neurol. 2012Oct19. [Epub ahead of print]
6.
LangdonDWAmatoMPBoringaJ. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler2012; 18: 891–898.
7.
Rao SM and the Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the Brief Repeatable Battery of Neuropsychological Tests in multiple sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
8.
Jennekens-SchinkelASandersEALanserJB. Reaction time in ambulant multiple sclerosis patients. Part I. Influence of prolonged cognitive effort. J Neurol Sci1988; 85: 173–186.
9.
SchulzDKoppBKunkelA. Cognition in the early stage of multiple sclerosis. J Neurol2006; 253: 1002–1010.
10.
BergendalGFredriksonSAlmkvistOSelective decline in information processing in subgroups of multiple sclerosis: An 8-year longitudinal study. Eur Neurol2007; 57: 193–202.
11.
RaoSMLeoGJBernardinL. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology1991; 41: 685–691.
12.
ZimmermannPFimmBTests d’évaluation de l’attention (TEA). Würselen: Psytest, 1994.
13.
TinnefeldMTreitzFHHaaseCG. Attention and memory dysfunctions in mild multiple sclerosis. Eur Arch Psychiatry Clin Neurosci2005; 255: 319–326.
14.
WechslerDWechsler Adult Intelligence Scale-III administration and scoring manual. San Antonio, TX: The Psychological Incorporation, 1997.
15.
BensaCBertogliatiCChanaletS. Early detection of cognitive impairment in relapsing–remitting multiple sclerosis: Functional-anatomical correlations and longitudinal follow-up. Rev Neurol (Paris)2006; 162: 1221–1231.
16.
DujardinKSockeelPCabaretM. BCcogSEP: A French test battery evaluating cognitive functions in multiple sclerosis. Rev Neurol (Paris)2004; 160: 51–62.
17.
SmithASymbol Digit Modalities Test (SDMT) Manual (revised). Los Angeles: Western Psychological Services, 1982.
18.
DeloireMSBonnetMCSalortE. How to detect cognitive dysfunction at early stages of multiple sclerosis?Mult Scler2006; 12: 445–452.
19.
ParmenterBAWeinstock-GuttmanBGargN. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler2007; 13: 52–57.
20.
BenedictRHDuquinJAJurgensenS. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler2008; 14: 940–946.
21.
MorrowSAO’ConnorPWPolmanCH. Evaluation of the Symbol Digit Modalities Test (SDMT) and MS Neuropsychological Screening Questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Mult Scler2010; 16: 1385–1392.
22.
LevineAJMillerENBeckerJT. Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol. 2004; 18: 373–384.
23.
BrochetBDeloireMSBonnetM. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Mult Scler2008; 14: 1242–1249.
24.
PolmanCHReingoldSCEdanG. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria.’Ann Neurol2005; 58: 840–846.
25.
ZimmermannPFimmBTAP 2.1 Tests d’évaluation de l’attention. Würzelen: Psytest2009. Zimmermann P and Fimm B. TAP 2.1 Tests d’évaluation de l’attention. Würzelen: Psytest, 2006.
26.
BrochetBAssessing incapacity at early stages of multiple sclerosis using the EDSS. Rev Neurol (Paris)2009; 165: S173–179.
27.
KurtzkeJFRating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology1983; 33: 1444–1452.
28.
BeckATBrownGSteerRABeck Depression Inventory II manual. San Antonio, TX: The Psychological Corporation, 1996.
29.
SpielbergCDManual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press, 1983.
30.
SharrackBHughesRAThe Guy’s Neurological Disability Scale (GNDS): A new disability measure for multiple sclerosis. Mult Scler1999; 5: 223–233.
31.
BenedictRAmatoMPBoringaJ. Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol2012; 12: 55.
32.
BenedictRHSmerbeckAParikhR. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: Implications for multiple sclerosis clinical trials. Mult Scler2012; 18: 1320–1325.
33.
DrakeASWeinstock-GuttmanBMorrowSA. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: Replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler2010; 16: 228–237.
34.
BoringaJBLazeronRHReulingIE. The brief repeatable battery of neuropsychological tests: Normative values allow application in multiple sclerosis clinical practice. Mult Scler2001; 7: 263–267.
